Dexcom Appoints Kyle Malady to Board of Directors
DexCom, Inc. (NASDAQ: DXCM) has appointed Kyle Malady to its Board of Directors, effective immediately. Malady currently serves as executive vice president and chief technology officer at Verizon, overseeing global network operations and IT functions. With over 30 years of experience in mobile communications technology, Malady's extensive background is expected to enhance DexCom's leadership in continuous glucose monitoring and data analytics. His appointment aims to bolster DexCom’s efforts to empower diabetes management.
- Kyle Malady brings over 30 years of expertise in mobile communications and technology, potentially strengthening Dexcom's strategic direction.
- His leadership experience at Verizon could enhance Dexcom's initiatives in data infrastructure and product development.
- None.
SAN DIEGO--(BUSINESS WIRE)--DexCom, Inc. (NASDAQ: DXCM), the global leader in real-time continuous glucose monitoring, today announced the appointment of Kyle Malady to its Board of Directors, effective immediately.
Mr. Malady currently serves as executive vice president of global networks and technology & chief technology officer at Verizon Communications Inc. Verizon is one of the world’s largest communication technology companies with greater than
“We are very excited to welcome Kyle to the Dexcom Board,” said Kevin Sayer, chairman, president and CEO at Dexcom. “Kyle is one of the world’s foremost leaders in his field and has established himself as an invaluable leader across several of Verizon’s key business units and product offerings over the course of his career. His experience and creativity provide a complementary fit with our efforts to leverage Dexcom’s CGM systems and data infrastructure to empower people to take control of their health.”
About Kyle Malady
Kyle Malady is executive vice president of global networks and technology & chief technology officer at Verizon Communications, Inc. He leads the company’s network operations, IT functions, data center management, and customer facing new product realization. Prior to assuming this role, Mr. Malady was head of the Core Engineering and Operations organization within the Global Network and Technology organization. He has also served as Verizon’s vice president of New Product Development, including an instrumental role in the development and commercialization of 4G LTE and the launch of platforms such as VCast Music and Video, VZ Navigator, Push to Talk, VZ MobileWeb, and the Verizon App Store. During his tenure he has held a variety of positions in operations, planning, technology, engineering and finance.
In addition to his experience at Verizon, Mr. Malady manages Caelens Fund, a charity that raises money to provide free cardiac surgeries for children in developing countries. Mr. Malady holds an MBA in finance from the NYU Stern School of Business and Bachelor of Science in Mechanical Engineering from the University of Bridgeport.
About DexCom, Inc.
Dexcom, Inc. empowers people to take control of diabetes through innovative continuous glucose monitoring (CGM) systems. Headquartered in San Diego, California, Dexcom has emerged as a leader of diabetes care technology. By listening to the needs of users, caregivers, and providers, Dexcom simplifies and improves diabetes management around the world.
